Clinical trial
Combination Of PAXIL Tablet And Benzodiazepines
NCT00259883 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00259883 |
|---|---|
| Title | Combination Of PAXIL Tablet And Benzodiazepines |
| Official title | Post-marketing Clinical Study on PAXIL Tablet in Patients With Depression or Depressive Mood - A Study on Combination of PAXIL Tablet and Benzodiazepines |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mental Disorders |
| Intervention type | Drug |
| Interventions | paroxetine |
| Enrollment | 150 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 18, 2017 |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: